Individual responses vary, and ongoing medical supervision is essential to optimise outcomes and manage any adverse effects
O/N at RT 475 L/well
record last updated October 2, 2023
Sorry, not sorry for the pun, but this should NOT be one size fits all, and the objective of #obesitydrugdevelopment should NOT merely be the most weight loss as fast as possible for everyone and the same dose for both wt loss and wt maintenance
Data from animal studies further suggest that the appetite suppressant (anorectic) effects of GLP-1R agonists are also manifested through mesolimbic GLP-1R activation, that in turn alters the rewarding value of food [23,24,25,26,27,28,29]
Our goal is to empower you to take control of your health, confidence, and future